Human Genome Sciences
Global healthcare company that is committed to helping people to do more, feel better, and live longer.
Launch date
Market cap
-
Enterprise valuation
€2.7b (Public information from Aug 2012)
Rockville Maryland (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | - | ||
$3.0b Valuation: $3.0b | Acquisition | ||
Total Funding | - |